Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
2016 ◽
Vol 100
(8)
◽
pp. e43-e44
◽
2016 ◽
Vol 48
(3)
◽
pp. 315-320
◽
2010 ◽
Vol 139
(5)
◽
pp. 1762-1773.e5
◽